Strategic Analysis of the U.S. Biopharmaceuticals Market

Strategic Analysis of the U.S. Biopharmaceuticals Market

 

RELEASE DATE
02-Dec-2008
REGION
North America
Research Code: N505-01-00-00-00
SKU: HC02105-NA-MR_07568
AvailableYesPDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC02105-NA-MR_07568

$4,950.00

$3,712.50save 25 %

DownloadLink
ENQUIRE NOW

Description

This research service covers the strategic analysis of the U.S. biopharmaceutical market 2004-2014. Included are technology trends, total market revenue forecasts, and selected market segment revenue forecasts. The market is segmented by product class: antisense, cytokines and proteins, enzymes and hormones, gene and cell therapies, and vaccines. Major market challenges, drivers, and restraints and identified and discussed. Also included is selected late stage pipeline analysis.

Table of Contents

Research Scope and Methodology

  • Scope and Segmentation
  • Research Methodology

Market Introduction

  • Market Engineering Measurements
  • Introduction
  • Main Classes of Biopharmaceuticals
  • Recent Product Approvals
  • Competitive Structure

Market Trends

  • Hot Topics and Trends
  • Industry Challenges
  • Market Drivers
  • Market Restraints

Pipeline Analysis

  • Introduction
  • Antisense Therapies
  • Gene and Cell Therapies
  • Hormones and Proteins
  • Interferons and Interleukins
  • Monoclonal Antibodies
  • Vaccines
  • Others

Total Market Forecasts

Select Sub Market Forecasts

Oncology Databases

Autoimmune and Inflammatory Disorders Databases

Organ Transplants Databases

Cardiovascular Disorders

Neurodegenerative Disorders Databases

  • Cancer Cases
  • Incidence of Breast Cancer
  • Incidence of Colon and Rectum Cancer
  • Incidence of Bladder Cancer
  • Incidence of Lung Cancer
  • Incidence of Stomach Cancer

Respiratory Disorders Databases

  • Prevalence of Arthritis
  • Prevalence of Psoriasis
  • Prevalence of Multiple Sclerosis

Miscellaneous Databases

  • The Total Number of Kidney Transplants
  • Total Number of Heart Transplants
  • Total Number of Liver Transplants
This research service covers the strategic analysis of the U.S. biopharmaceutical market 2004-2014. Included are technology trends, total market revenue forecasts, and selected market segment revenue forecasts. The market is segmented by product class: antisense, cytokines and proteins, enzymes and hormones, gene and cell therapies, and vaccines. Major market challenges, drivers, and restraints and identified and discussed. Also included is selected late stage pipeline analysis.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number N505-01-00-00-00
Is Prebook No